BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31393240)

  • 1. Recent Progress of Benzimidazole Hybrids for Anticancer Potential.
    Akhtar MJ; Yar MS; Sharma VK; Khan AA; Ali Z; Haider MDR; Pathak A
    Curr Med Chem; 2020; 27(35):5970-6014. PubMed ID: 31393240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
    Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
    Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021).
    Feng LS; Su WQ; Cheng JB; Xiao T; Li HZ; Chen DA; Zhang ZL
    Arch Pharm (Weinheim); 2022 Jun; 355(6):e2200051. PubMed ID: 35385159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Anti-Cancer Applications of Benzimidazole Derivatives - Recent Studies.
    Tyagi YK; Jali G; Singh R
    Anticancer Agents Med Chem; 2022; 22(19):3280-3290. PubMed ID: 36221180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzimidazole derivatives as potential anticancer agents.
    El Rashedy AA; Aboul-Enein HY
    Mini Rev Med Chem; 2013 Mar; 13(3):399-407. PubMed ID: 23190032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development.
    Monga J; Ghosh NS; Rani I; Singh R; Deswal G; Dhingra AK; Grewal AS
    Curr Top Med Chem; 2024; 24(5):437-485. PubMed ID: 38311918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Approach to Potential Anticancer Benzimidazole Derivatives: A Review.
    Kumar R; Singh C; Mazumder A; Salahuddin ; Abdullah MM; Kumar V; Giri PP
    Mini Rev Med Chem; 2022; 22(9):1289-1304. PubMed ID: 34598663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era.
    Yadav S; Narasimhan B; Kaur H
    Anticancer Agents Med Chem; 2016; 16(11):1403-1425. PubMed ID: 26526461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
    Łukowska-Chojnacka E; Wińska P; Wielechowska M; Poprzeczko M; Bretner M
    Bioorg Med Chem; 2016 Feb; 24(4):735-41. PubMed ID: 26778657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review.
    Yadav G; Ganguly S
    Eur J Med Chem; 2015 Jun; 97():419-43. PubMed ID: 25479684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the structure and drug design of benzimidazole derivatives targeting the epidermal growth factor receptor (EGFR).
    Abdullah MN; Ali Y; Abd Hamid S
    Chem Biol Drug Des; 2022 Dec; 100(6):921-934. PubMed ID: 34651438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
    Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
    Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzimidazole: A Milestone in the Field of Medicinal Chemistry.
    Vasava MS; Bhoi MN; Rathwa SK; Jethava DJ; Acharya PT; Patel DB; Patel HD
    Mini Rev Med Chem; 2020; 20(7):532-565. PubMed ID: 31755386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
    Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
    J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel potential anticancer agents derived from benzimidazole.
    Ibrahim ES; Omar AM; Khalil MA
    J Pharm Sci; 1980 Nov; 69(11):1348-50. PubMed ID: 7452470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase.
    White AW; Almassy R; Calvert AH; Curtin NJ; Griffin RJ; Hostomsky Z; Maegley K; Newell DR; Srinivasan S; Golding BT
    J Med Chem; 2000 Nov; 43(22):4084-97. PubMed ID: 11063605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives.
    el-Hawash SA; Badawey el-S A; Kappe T
    Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicophoric and metabolic in silico evaluation of benzimidazole and phenylbenzamide derivatives with potential application as anticancer agents.
    da Silva VB; Leopoldino AM; Taft CA; da Silva CH
    Drug Metab Lett; 2011 Dec; 5(4):267-75. PubMed ID: 22292473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New substituted benzimidazole derivatives: a patent review (2013 - 2014).
    Wang M; Han X; Zhou Z
    Expert Opin Ther Pat; 2015 May; 25(5):595-612. PubMed ID: 25887338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic journey of benzimidazoles: a review.
    Bansal Y; Silakari O
    Bioorg Med Chem; 2012 Nov; 20(21):6208-36. PubMed ID: 23031649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.